Abstract
*Laboratory for Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam; Department of InternalMedicine, Slotervaart Hospital, Amsterdam; Laboratory of Haematology and Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam; and§Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Academic Hospital and University of Maastricht, Maastricht,The NetherlandsTo cite this article: Sommeijer DW, Joop K, Leyte A, Reitsma PH, ten Cate H. Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derivedmicroparticles in patients with type 2 diabetes. J Thromb Haemost 2005; 3: 1168–71.See also Davi` G, Ferroni P. Microparticles in type 2 diabetes mellitus. This issue, pp 1166–7.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
